document_id
stringlengths 32
32
| age
int64 17
105
| gender
stringclasses 2
values | test_name
stringlengths 1
100
⌀ | display_ranges
stringlengths 1
662
⌀ | value
stringlengths 1
255
| unit
stringlengths 1
15
⌀ | specimen
stringclasses 12
values | loinc
stringclasses 581
values |
---|---|---|---|---|---|---|---|---|
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | % TRANSFERRIN SATURATION | null | 25.4100 | % | blood | 2502-3 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | IRON | null | 98.6000 | ug/dl | null | 2498-4 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | TOTAL IRON BINDING CAPACITY (TIBC) | null | 388.0000 | ug/dl | blood | 2500-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | ALANINE TRANSAMINASE (SGPT) | < 34.0 | 29.4600 | U/I | blood | 1742-6 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | ALBUMIN SERUM | 3.2 - 4.8 | 4.4400 | gm/dl | blood | 1751-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | ALKALINE PHOSPHATASE | 45.0 - 129.0 | 63.8300 | U/L | blood | 6768-6 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | ASPARTATE AMINOTRANSFERASE (SGOT ) | < 31.0 | 26.9200 | U/I | blood | 1920-8 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | BILIRUBIN (INDIRECT) | 0.0 - 0.9 | 0.4800 | mg/dl | blood | 1971-1 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | BILIRUBIN -DIRECT | < 0.3 | 0.2100 | mg/dl | blood | 1968-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | BILIRUBIN TOTAL | 0.3 - 1.2 | 0.6900 | mg/dl | blood | 1975-2 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | GAMMA GLUTAMYL TRANSFERASE (GGT) | < 38.0 | 75.8900 | U/I | blood | 2324-2 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | PROTEIN TOTAL | 5.7 - 8.2 | 7.3800 | gm/dl | blood | 2885-2 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | SERUM ALB/GLOBULIN RATIO | 0.9 - 2.0 | 1.5100 | Ratio | blood | 1759-0 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | SERUM GLOBULIN | 2.5 - 3.4 | 2.9400 | gm/dL | blood | 2336-6 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | HDL CHOLESTEROL DIRECT | 35.0 - 80.0 | 73.0000 | mg/dl | blood | 2085-9 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | LDL / HDL RATIO | 1.5 - 3.5 | 0.9000 | Ratio | blood | 11054-4 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | LDL CHOLESTEROL DIRECT | 85.0 - 130.0 | 64.0000 | mg/dl | blood | 2089-1 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | NON-HDL CHOLESTEROL | < 160.0 | 101.2500 | mg/dl | blood | 43396-1 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | TC/ HDL CHOLESTEROL RATIO | 3.0 - 5.0 | 2.4000 | Ratio | blood | 9830-1 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | TOTAL CHOLESTEROL | 125.0 - 200.0 | 174.0000 | mg/dl | blood | 2093-3 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | TRIGLYCERIDES | 25.0 - 200.0 | 137.0000 | mg/dl | blood | 2571-8 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | VLDL CHOLESTEROL | 5.0 - 40.0 | 27.3900 | mg/dl | blood | 2091-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | THYROID STIMULATING HORMONE (TSH) | 0.3 - 5.5 | 0.4700 | uIU/ml | blood | 3016-3 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | TOTAL THYROXINE (T4) | 4.5 - 12.0 | 6.0000 | ug/dl | blood | 3026-2 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | TOTAL TRIIODOTHYRONINE (T3) | 60.0 - 200.0 | 97.0000 | ng/dl | blood | 3053-6 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | BLOOD UREA NITROGEN (BUN) | 7.0 - 25.0 | 13.4100 | mg/dl | blood | 3094-0 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | BUN / SR.CREATININE RATIO | 9:1-23:1 | 26.2900 | Ratio | blood | 3097-3 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | CALCIUM | 8.8 - 10.6 | 9.3500 | mg/dl | blood | 17861-6 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | CREATININE SERUM | 0.5 - 0.8 | 0.5100 | mg/dl | blood | 2160-0 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | URIC ACID | 3.2 - 6.1 | 5.8400 | mg/dl | blood | 3084-1 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | EST. GLOMERULAR FILTRATION RATE (eGFR) | null | 96.0000 | mL/min/1.73 m2 | blood | 69405-9 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | AVERAGE BLOOD GLUCOSE (ABG) | null | 143.0000 | mg/dl | blood | 27353-2 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | HbA1c (HPLC NGSP Certified) | null | 6.6000 | % | blood | 4548-4 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | BASOPHILS | < 2.0 | 0.2000 | % | blood | 30180-4 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | BASOPHILS ABSOLUTE COUNT | 0.02 - 0.1 | 0.0200 | X 10 ³ / uL | blood | 26444-0 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | EOSINOPHILS | 0.0 - 6.0 | 4.5000 | % | blood | 26450-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | EOSINOPHILS ABSOLUTE COUNT | 0.02 - 0.5 | 0.3400 | X 103 / pL | blood | 26449-9 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | HEMATOCRIT(PCV) | 36.0 - 46.0 | 42.4000 | % | blood | 20570-8 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | HEMOGLOBIN | 12.0 - 15.0 | 12.5000 | g/dL | blood | 718-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | IMMATURE GRANULOCYTE PERCENTAGE(IG%) | 0.0 - 0.4 | 0.1000 | % | blood | 38518-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | IMMATURE GRANULOCYTES(IG) | 0.0 - 0.3 | 0.0100 | X 10³ / uL | blood | 51584-1 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | LYMPHOCYTE PERCENTAGE | 20.0 - 40.0 | 27.8000 | % | blood | 26478-8 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | LYMPHOCYTES ABSOLUTE COUNT | 1.0 - 3.0 | 2.1200 | X 10 ³ / uL | blood | 26474-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | MEAN CORP.HEMO.CONC(MCHC) | 31.5 - 34.5 | 29.5000 | g/dL | blood | 28540-3 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | MEAN CORPUSCULAR HEMOGLOBIN(MCH) | 27.0 - 32.0 | 29.1000 | pq | blood | 28539-5 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | MEAN CORPUSCULAR VOLUME(MCV) | 83.0 - 101.0 | 98.6000 | fL | blood | 30428-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | MEAN PLATELET VOLUME(MPV) | 6.5 - 12.0 | 14.6000 | fL | blood | 28542-9 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | MONOCYTES | 0.0 - 10.0 | 5.1000 | % | blood | 26485-3 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | MONOCYTES ABSOLUTE COUNT | 0.2 - 1.0 | 0.3900 | X 10 superscrip | blood | 26484-6 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | NEUTROPHILS | 40.0 - 80.0 | 62.3000 | % | blood | 53797-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | NEUTROPHILS ABSOLUTE COUNT | 2.0 - 7.0 | 475.0000 | X 103/uL | blood | 26499-4 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | NUCLEATED RED BLOOD CELLS | <0.01 | nil | X 103/UL | blood | null |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | NUCLEATED RED BLOOD CELLS % | <0.01 | nil | % | blood | 19048-8 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | PLATELET COUNT | 150.0 - 400.0 | 173.0000 | X 10 ³ / uL | blood | 26515-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | PLATELET TO LARGE CELL RATIO(PLCR) | 19.7 - 42.4 | 63.6000 | % | blood | 48386-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | PLATELETCRIT(PCT) | 0.19 - 0.39 | 0.2500 | % | blood | 51637-7 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | RED CELL DISTRIBUTION WIDTH SD(RDW-SD) | 39.0 - 46.0 | 54.5000 | fL | blood | 30384-2 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | TOTAL LEUCOCYTES COUNT | 4.0 - 10.0 | 7.6200 | X 10 ³ / uL | blood | 26464-8 |
a1ce7f03fca11a7351927f5d6d635552 | 72 | female | TOTAL RBC | 3.9 - 4.8 | 4.3000 | X 10^6/uL | blood | 26453-1 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Absolute Eosinophil Count | 20.0 - 500.0 | 216.7500 | cells/micro L | blood | 26449-9 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Absolute Lymphocyte Count | 1000.0 - 3000.0 | 2384.2500 | cells/micro L | blood | 26474-7 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Absolute Neutrophil Count | 2000.0 - 7000.0 | 5644.1700 | cells/micro L | blood | 26499-4 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Basophils | < 2.0 | 0.6000 | % | blood | 30180-4 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Eosinophils | 1.0 - 6.0 | 2.5000 | % | blood | 26450-7 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Haemoglobin-HB | 13.0 - 17.0 | 14.1000 | g/dL | blood | 718-7 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Lymphocytes | 20.0 - 40.0 | 27.5000 | % | blood | 26478-8 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | MCH (Mean Corpuscular Haemoglobin) | 27.0 - 32.0 | 29.1000 | pg | blood | 28539-5 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | MCHC (Mean Corpuscular Haemoglobin | 31.5 - 34.5 | 33.0000 | g/dL | blood | 28540-3 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | MCV (Mean Corpuscular Volume) | 83.0 - 101.0 | 88.0000 | fL | blood | 30428-7 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Monocytes | 2.0 - 10.0 | 4.3000 | % | blood | 26485-3 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | N/L Ratio | 1.0 - 3.0 | 2.3700 | ratio | null | null |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Neutrophils | 40.0 - 80.0 | 65.1000 | % | blood | 53797-7 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | PCV (Haematocrit) | 40.0 - 50.0 | 42.7000 | % | blood | 20570-8 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Red Cell Distribution Width CV | 11.5 - 15.0 | 13.4000 | % | blood | 30385-9 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Red Cell Distribution Width SD | 39.0 - 46.0 | 43.5000 | fL | blood | 30384-2 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Total RBC Count | 4.5 - 5.5 | 4.8500 | Million/uL | blood | 26453-1 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Total WBC Count | 4000.0 - 10000.0 | 8670.0000 | cells/cumm | blood | 26464-8 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Absolute Basophil Count | 20.0 - 100.0 | 52.0200 | cells/micro L | blood | 26444-0 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Absolute Monocyte Count | 200.0 - 1000.0 | 372.8100 | cells/micro L | blood | 26484-6 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | ESR (Erythrocyte Sedimentation Rate) | 5.0 - 20.0 | 18.0000 | mm/hr | blood | 30341-2 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Estimated Average Glucose (eAG) | null | 108.2800 | mg/dl | blood | 27353-2 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Glycosylated Haemoglobin-HbA1c | impaired glucose tolerance: 5.7
6.4
diabetes: > 6.5
non diabetic level: < 5.70 | 5.4000 | % | blood | 4548-4 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | HDL Cholesterol-Direct | 40.0 - 60.0 | 46.0700 | mg/dL | blood | 2085-9 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Mean Platelet volume | 6.5 - 12.0 | 10.9000 | fL | blood | 28542-9 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Platelet Count | 150.0 - 450.0 | 318.0000 | Thousand/uL | blood | 26515-7 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Platelet distribution width-CV | null | 13.0000 | % | blood | 51631-0 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Platelet distribution width-SD | null | 9.5000 | fL | blood | 32207-3 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Platelet to large cell ratio (PLCR) | 19.7 - 42.4 | 31.8000 | % | blood | 48386-7 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Plateletcrit | 19.7 - 42.4 | 35.0000 | % | blood | 51637-7 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Total Cholesterol | borderline high: 200-239
high: > 239
desirable: < 200 | 237.8900 | mg/dL | blood | 2093-3 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Triglycerides | normal: < 150
high: 150-199
hypertriglyceridemic: 200-499
very high: > 500 | 125.5600 | mg/dL | blood | 2571-8 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | BUN-Blood Urea Nitrogen | 6.0 - 20.0 | 7.6900 | mg/dL | blood | 3094-0 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Bicarbonate | 23.0 - 29.0 | 25.0000 | mEq/L | blood | 1963-8 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Chloride | 98.0 - 107.0 | 102.0000 | mEq/L | blood | 2075-0 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Cholesterol / Hdl Ratio | 3.9 - 5.0 | 5.1600 | ratio | blood | 9830-1 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Creatinine | 0.62 - 1.1 | 0.9200 | mg/dL | blood | 2160-0 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | LDL / HDL Ratio | high risk: more than 6.0
borderline: 3.0-4.0
optimal: less than 3.0 | 3.6400 | ratio | blood | 11054-4 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | LDL Cholesterol-Direct | optimal: < 100
near optimal/above optimal: 100
129
borderline high: 130-159
high: 160-189
very high: > 190 | 167.5700 | mg/dL | blood | 2089-1 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Non Hdl Cholesterol | < 140.0 | 191.8200 | mg/dL | blood | 43396-1 |
7cb374e4e2b825c5af8206157026b16f | 40 | male | Potassium | 3.5 - 5.1 | 3.8000 | mEq/L | blood | 2823-3 |
NidaanKosha
A Comprehensive Laboratory Investigation Dataset of 100,000 Indian Subjects with 6.8 Million+ Readings
In Sanskrit, "Nidaan" (निदान) signifies "diagnosis" or "investigation," while "Kosha" (कोष) represents a "treasury" or "repository." Together, NidaanKosha embodies a valuable collection of diagnostic information, preserving vital health insights for research and innovation.
Dataset Overview
NidaanKosha is an extensive repository containing laboratory investigation readings from 100,000 lab reports collected across diverse diagnostic facilities throughout India. This comprehensive dataset represents a curated collection of data extracted through Eka Care's Parrotlet vision LLM, which automatically parse images and PDFs to extract structured health information. The dataset contains approximately 6.8 million individual investigation readings, each mapped to standardized LOINC identifiers for interoperability.
- Curated and Shared by: Eka.Care
- License: CC-BY-SA-4.0
Data Acquisition
The laboratory investigation readings were extracted from lab reports collected through Eka Care's Personal Health Record applications:
- Applications: Eka Care PHR mobile applications
Data Structure and Parameters
The dataset provides a rich collection of laboratory investigation readings with the following key attributes:
Core Components
- document_id: Unique identifier for each lab report
- age: Age of the subject (as specified in the report)
- gender: Gender of the subject (as specified in the report)
- test_name: Extracted name of the lab investigation from the report
- value: Measured value of the investigation
- unit: Unit of measurement for the investigation value
- display_ranges: Reference range for the specific investigation (specified in the row of the lab test, these readings are not read from the reference range table often provided in lab reports)
- specimen: Identified Specimen of the lab investigation
- loinc: LOINC code of the lab investigation (Automatically done)
Demographic Information
- Gender-balanced dataset to ensure representative insights
- Geographic distribution across various regions in India
Extraction Methodology
Parrotlet AI Model Series
The laboratory values were automatically extracted using Eka Care's proprietary Parrotlet series of AI models, specifically designed to:
- Parse both image and PDF formats of lab reports
- Identify and extract relevant investigation parameters
- Map extractions to standardized LOINC codes
- Maintain high accuracy and reliability in data extraction
Potential Applications
- Population health studies specific to Indian demographics
- Medical research on reference ranges in Indian populations
- Benchmarking and improving laboratory data extraction models
- Training and validation of health data interoperability systems
Dataset Creation Methodology
Data Collection and Processing
The shared corpus is a carefully selected subset of data collected through Eka Care's PHR applications. The dataset has been curated to ensure diversity across gender and geographic representation while maintaining quality and completeness of extracted information.
Privacy Considerations
This dataset contains absolutely no personally identifiable information (PII) and is completely anonymized. All document identifiers have been randomized to prevent any connection to original users.
References
- Lab-Ready and Prescription-Perfect: Eka Care's Small LLMs vs. Industry Giants
- Extracting Structured Information from Lab Reports: Challenges and Learnings
Examples of Studies done with dataset
- The Quiet Threat: Understanding Latent Iron Deficiency
- Cholesterol Chronicles - The Indian Disadvantage
Contact Information
For inquiries, please email with the subject line "NidaanKosha enquiry" to: sankalp [at] eka.care
- Downloads last month
- 1